Prolactin and epidermal growth factor stimulate adipophilin synthesis in HC11 mouse mammary epithelial cells via the PI3-kinase/Akt/mTOR pathway

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 5, 2012, Pages 987-996

  Pauloin, Alain ^a   Chanat, Eric ^a  

^a INRA Institut National de la Recherche Agronomique   (France)

Author keywords

Casein; HC11 cell; Lactation; Mammary epithelial cell; PI3K Akt; Prolactin

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADIPOPHILIN; BETA CASEIN; CYTOPLASM PROTEIN; CYTOPLASMIC LIPID DROPLET ASSOCIATED PROTEIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HYDROCORTISONE; JANUS KINASE 2; MAMMALIAN TARGET OF RAPAMYCIN; MILK FAT; MILK PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MK 2206; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; OLEIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROLACTIN; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; RAF PROTEIN; RAPAMYCIN; RAS PROTEIN; STAT5A PROTEIN; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; IMMUNOFLUORESCENCE MICROSCOPY; LIPID STORAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; WESTERN BLOTTING;

ANIMALS; CASEINS; CELL LINE; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; FEMALE; JANUS KINASE 2; MAMMARY GLANDS, ANIMAL; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; MICE; MODELS, BIOLOGICAL; OLEIC ACID; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROLACTIN; PROTEIN BIOSYNTHESIS; PROTEIN KINASE INHIBITORS; PROTEIN SYNTHESIS INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-JUN; SHEEP; STAT5 TRANSCRIPTION FACTOR; TOR SERINE-THREONINE KINASES;

EID: 84859198477     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.02.016     Document Type: Article

References (74)

1. Heid H.W., Keenan T.W. Intracellular origin and secretion of milk fat globules. Eur. J. Cell Biol. 2005, 84:245-258.
2. Hennighausen L., Robinson G.W., Wagner K.U., Liu X.W. Prolactin signaling in mammary gland development. J. Biol. Chem. 1997, 272:7567-7569.
3. Doppler W., Hock W., Hofer P., Groner B., Ball R.K. Prolactin and glucocorticoid hormones control transcription of the beta-casein gene by kinetically distinct mechanisms. Mol. Endocrinol. 1990, 4:912-919.
4. Stocklin E., Wissler M., Gouilleux F., Groner B. Functional interactions between Stat5 and the glucocorticoid receptor. Nature 1996, 383:726-728.
5. Wyszomierski S.L., Yeh J., Rosen J.M. Glucocorticoid receptor/signal transducer and activator of transcription 5 (STAT5) interactions enhance STAT5 activation by prolonging STAT5 DNA binding and tyrosine phosphorylation. Mol. Endocrinol. 1999, 13:330-343.
6. Clevenger C.V., Torigoe T., Reed J.C. Prolactin induces rapid phosphorylation and activation of prolactin receptor-associated RAF-1 kinase in a T-cell line. J. Biol. Chem. 1994, 269:5559-5565.
7. Das R., Vonderhaar B.K. Activation of raf-1, MEK, and MAP kinase in prolactin responsive mammary cells. Breast Cancer Res. Treat. 1996, 40:141-149.
8. Bole-Feysot C., Goffin V., Edery M., Binart N., Kelly P.A. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr. Rev. 1998, 19:225-268.
9. Clevenger C.V., Furth P.A., Hankinson S.E., Schuler L.A. The role of prolactin in mammary carcinoma. Endocr. Rev. 2003, 24:1-27.
10. Sakamoto K., Creamer B.A., Triplett A.A., Wagner K.U. The Janus kinase 2 is required for expression and nuclear accumulation of cyclin D1 in proliferating mammary epithelial cells. Mol. Endocrinol. 2007, 21:1877-1892.
11. Kannan S., De Santis M., Lohmeyer M., Riese D.J., Smith G.H., Hynes N., Seno M., Brandt R., Bianco C., Persico G., Kenney N., Normanno N., Martinez-Lacaci I., Ciardiello F., Stern D.F., Gullick W.J., Salomon D.S. Cripto enhances the tyrosine phosphorylation of Shc and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cells. J. Biol. Chem. 1997, 272:3330-3335.
12. Lewis T.S., Shapiro P.S., Ahn N.G. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 1998, 74:49-139.
13. De Santis M.L., Kannan S., Smith G.H., Seno M., Bianco C., Kim N., Martinez-Lacaci I., Wallace-Jones B., Salomon D.S. Cripto-1 inhibits beta-casein expression in mammary epithelial cells through a p21ras-and phosphatidylinositol 3'-kinase-dependent pathway. Cell Growth Differ. 1997, 8:1257-1266.
14. Vivanco I., Sawyers C.L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2002, 2:489-501.
15. Sato J.D., Kawamoto T., Le A.D., Mendelsohn J., Polikoff J., Sato G.H. Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. Mol. Biol. Med. 1983, 1:511-529.
16. Hynes N.E., Taverna D., Harwerth I.M., Ciardiello F., Salomon D.S., Yamamoto T., Groner B. Epidermal growth factor receptor, but not c-erbB-2, activation prevents lactogenic hormone induction of the beta-casein gene in mouse mammary epithelial cells. Mol. Cell. Biol. 1990, 10:4027-4034.
17. Groner B., Gouilleux F. Prolactin-mediated gene activation in mammary epithelial cells. Curr. Opin. Genet. Dev. 1995, 5:587-594.
18. Petersen H., Haldosen L.A. EGF modulates expression of STAT5 in mammary epithelial cells. Exp. Cell Res. 1998, 243:347-358.
19. Ruff-Jamison S., Chen K., Cohen S. Epidermal growth factor induces the tyrosine phosphorylation and nuclear translocation of Stat 5 in mouse liver. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:4215-4218.
20. Richer J.K., Lange C.A., Manning N.G., Owen G., Powell R., Horwitz K.B. Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity. J. Biol. Chem. 1998, 273:31317-31326.
21. Cameron C.M., Linebaugh B.E., Rillema J.A. Hormonal control of lipid metabolism in mouse mammary gland explants. Endocrinology 1983, 112:1007-1011.
22. Neville M.C., Picciano M.F. Regulation of milk lipid secretion and composition. Annu. Rev. Nutr. 1997, 17:159-183.
23. Ollivier-Bousquet M. Milk lipid and protein traffic in mammary epithelial cells: joint and independent pathways. Reprod. Nutr. Dev. 2002, 42:149-162.
24. Pauloin A., Chat S., Péchoux C., Hue-Beauvais C., Droineau S., Galio L., Devinoy E., Chanat E. Oleate and linoleate stimulate the degradation of b-casein in prolactin-treated HC11 mouse mammary epithelial cells. Cell Tissue Res. 2010, 340:91-102.
25. Ball R.K., Friis R.R., Schoenenberger C.A., Doppler W., Groner B. Prolactin regulation of b-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line. EMBO J. 1988, 7:2089-2095.
26. Kimmel A.R., Brasaemle D.L., McAndrews-Hill M., Sztalryd C., Londos C. Adoption of PERILIPIN as a unifying nomenclature for the mammalian PAT-family of intracellular lipid storage droplet proteins. J. Lipid Res. 2010, 51:468-471.
27. Brasaemle D.L., Barber T., Wolins N.E., Serrero G., Blanchette-Mackie E.J., Londos C. Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet-associated protein. J. Lipid Res. 1997, 38:2249-2263.
28. Strober W. Trypan blue exclusion test of cell viability. Curr. Protoc. Immunol., Appendix 2001, 3. Appendix.
29. Ohsaki Y., Maeda T., Fujimoto T. Fixation and permeabilization protocol is critical for the immunolabeling of lipid droplet proteins. Histochem. Cell Biol. 2005, 124:445-452.
30. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 277:680-685.
31. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. J. Biol. Chem. 1979, 76:4350-4354.
32. Doppler W., Groner B., Ball R.K. Prolactin and glucocorticoid hormones synergistically induce expression of transfected rat beta-casein gene promoter constructs in a mammary epithelial cell line. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:104-108.
33. Chanat E., Martin P., Ollivier-Bousquet M. Alpha(S1)-casein is required for the efficient transport of beta- and kappa-casein from the endoplasmic reticulum to the Golgi apparatus of mammary epithelial cells. J. Cell Sci. 1999, 112:3399-3412.
34. Xie J., LeBaron M.J., Nevalainen M.T., Rui H. Role of tyrosine kinase Jak2 in prolactin-induced differentiation and growth of mammary epithelial cells. J. Biol. Chem. 2002, 277:14020-14030.
35. Shan L., Zhang R., Zhang W., Lee E., Sridhar R., Snyderwine E.G., Wang P.C. Image-based evaluation of the molecular events underlying HC11 mammary epithelial cell differentiation. Anal. Biochem. 2008, 382:122-128.
36. Taverna D., Groner B., Hynes N.E. Epidermal growth factor receptor, platelet-derived growth factor receptor, and c-erbB-2 receptor activation all promote growth but have distinctive effects upon mouse mammary epithelial cell differentiation. Cell Growth Differ. 1991, 2:145-154.
37. Topper Y.J., Freeman C.S. Multiple hormone interactions in the developmental biology of the mammary gland. Physiol. Rev. 1980, 60:1049-1106.
38. Cerrito M.G., Galbaugh T., Wang W., Chopp T., Salomon D., Cutler M.L. Dominant negative Ras enhances lactogenic hormone-induced differentiation by blocking activation of the Raf-Mek-Erk signal transduction pathway. J. Cell. Physiol. 2004, 201:244-258.
39. Pang L., Sawada T., Decker S.J., Saltiel A.R. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 1995, 270:13585-13588.
40. Rillema J.A., Rowady D.L. Characteristics of the prolactin stimulation of c-fos mRNA levels in mouse mammary gland explants. Proc. Soc. Exp. Biol. Med. 1996, 212:142-146.
41. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:13681-13686.
42. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., Lee J.C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 1995, 364:229-233.
43. Ratovondrahona D., Fournier B., Odessa M.F., Dufy B. Prolactin stimulation of phosphoinositide metabolism in CHO cells stably expressing the PRL receptor. Biochem. Biophys. Res. Commun. 1998, 243:127-130.
44. Bjorge J.D., Chan T.O., Antczak M., Kung H.J., Fujita D.J. Activated type I phosphatidylinositol kinase is associated with the epidermal growth factor (EGF) receptor following EGF stimulation. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:3816-3820.
45. Hirai H., Sootome H., Nakatsuru Y., Miyama K., Taguchi S., Tsujioka K., Ueno Y., Hatch H., Majumder P.K., Pan B.S., Kotani H. MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo. Mol. Cancer Ther. 2010, 9:1956-1967.
46. Jankiewicz M., Groner B., Desrivieres S. Mammalian target of rapamycin regulates the growth of mammary epithelial cells through the inhibitor of deoxyribonucleic acid binding Id1 and their functional differentiation through Id2. Mol. Endocrinol. 2006, 20:2369-2381.
47. Liu R., Liu D., Trink E., Bojdani E., Ning G., Xing M. The Akt-specific inhibitor MK2206 selectively inhibits thyroid cancer cells harboring mutations that can activate the PI3K/Akt pathway. J. Clin. Endocrinol. Metab. 2011, 96:E577-E585.
48. Galbaugh T., Cerrito M.G., Jose C.C., Cutler M.L. EGF-induced activation of Akt results in mTOR-dependent p70S6 kinase phosphorylation and inhibition of HC11 cell lactogenic differentiation. BMC Cell Biol. 2006, 7:34.
49. Yonezawa T., Haga S., Kobayashi Y., Katoh K., Obara Y. Regulation of hormone-sensitive lipase expression by saturated fatty acids and hormones in bovine mammary epithelial cells. Biochem. Biophys. Res. Commun. 2008, 376:36-39.
50. Kliewer S.A., Sundseth S.S., Jones S.A., Brown P.J., Wisely G.B., Koble C.S., Devchand P., Wahli W., Willson T.M., Lenhard J.M., Lehmann J.M. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:4318-4323.
51. Targett-Adams P., McElwee M.J., Ehrenborg E., Gustafsson M.C., Palmer C.N., McLauchlan J. A PPAR response element regulates transcription of the gene for human adipose differentiation-related protein. Biochim. Biophys. Acta 2005, 1728:95-104.
52. Olsen H., Haldosen L.A. Peroxisome proliferator-activated receptor gamma regulates expression of signal transducer and activator of transcription 5A. Exp. Cell Res. 2006, 312:1371-1380.
53. Starr R., Hilton D.J. Negative regulation of the JAK/STAT pathway. Bioessays 1999, 21:47-52.
54. Horsch K., Schaller M.D., Hynes N.E. The protein tyrosine phosphatase-PEST is implicated in the negative regulation of epidermal growth factor on PRL signaling in mammary epithelial cells. Mol. Endocrinol. 2001, 15:2182-2196.
55. Tonko-Geymayer S., Goupille O., Tonko M., Soratroi C., Yoshimura A., Streuli C., Ziemiecki A., Kofler R., Doppler W. Regulation and function of the cytokine-inducible SH-2 domain proteins, CIS and SOCS3, in mammary epithelial cells. Mol. Endocrinol. 2002, 16:1680-1695.
56. Hazzalin C.A., Cuenda A., Cano E., Cohen P., Mahadevan L.C. Effects of the inhibition of p38/RK MAP kinase on induction of five fos and jun genes by diverse stimuli. Oncogene 1997, 15:2321-2331.
57. Olazabal I., Munoz J., Ogueta S., Obregon E., Garcia-Ruiz J.P. Prolactin (PRL)-PRL receptor system increases cell proliferation involving JNK (c-Jun amino terminal kinase) and AP-1 activation: inhibition by glucocorticoids. Mol. Endocrinol. 2000, 14:564-575.
58. Gutzman J.H., Rugowski D.E., Schroeder M.D., Watters J.J., Schuler L.A. Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells. Mol. Endocrinol. 2004, 18:3064-3075.
59. Eyers P.A., van den I.J., Quinlan R.A., Goedert M., Cohen P. Use of a drug-resistant mutant of stress-activated protein kinase 2a/p38 to validate the in vivo specificity of SB 203580. FEBS Lett. 1999, 451:191-196.
60. Andersson L., Bostrom P., Ericson J., Rutberg M., Magnusson B., Marchesan D., Ruiz M., Asp L., Huang P., Frohman M.A., Boren J., Olofsson S.O. PLD1 and ERK2 regulate cytosolic lipid droplet formation. J. Cell Sci. 2006, 119:2246-2257.
61. Gibson S., Tu S., Oyer R., Anderson S.M., Johnson G.L. Epidermal growth factor protects epithelial cells against Fas-induced apoptosis. Requirement for Akt activation. J. Biol. Chem. 1999, 274:17612-17618.
62. al Sakkaf K.A., Mooney L.M., Dobson P.R., Brown B.L. Possible role for protein kinase B in the anti-apoptotic effect of prolactin in rat Nb2 lymphoma cells. J. Endocrinol. 2000, 167:85-92.
63. Schwertfeger K.L., McManaman J.L., Palmer C.A., Neville M.C., Anderson S.M. Expression of constitutively activated Akt in the mammary gland leads to excess lipid synthesis during pregnancy and lactation. J. Lipid Res. 2003, 44:1100-1112.
64. Rudolph M.C., McManaman J.L., Hunter L., Phang T., Neville M.C. Functional development of the mammary gland: use of expression profiling and trajectory clustering to reveal changes in gene expression during pregnancy, lactation, and involution. J. Mammary. Gland. Biol. Neoplasia 2003, 8:287-307.
65. Boxer R.B., Stairs D.B., Dugan K.D., Notarfrancesco K.L., Portocarrero C.P., Keister B.A., Belka G.K., Cho H., Rathmell J.C., Thompson C.B., Birnbaum M.J., Chodosh L.A. Isoform-specific requirement for Akt1 in the developmental regulation of cellular metabolism during lactation. Cell Metab. 2006, 4:475-490.
66. Sekulic A., Hudson C.C., Homme J.L., Yin P., Otterness D.M., Karnitz L.M., Abraham R.T. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res. 2000, 60:3504-3513.
67. Hang J., Rillema J.A. Possible involvement of P13K in prolactin-stimulated milk product formation and iodide transport in mouse mammary explants. Proc. Soc. Exp. Biol. Med. 1998, 219:154-159.
68. Hang J.Q., Rillema J.A. Effect of rapamycin on prolactin-stimulated S6 kinase activity and milk product formation in mouse mammary explants, Bba. Mol. Cell Res. 1997, 1358:209-214.
69. Bishop J.D., Nien W.L., Dauphinee S.M., Too C.K. Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells. J. Endocrinol. 2006, 190:307-312.
70. Gandin V., Brina D., Marchisio P.C., Biffo S. JNK inhibition arrests cotranslational degradation. Biochim. Biophys. Acta 2010, 1803:826-831.
71. Vacaresse N., Lajoie-Mazenc I., Auge N., Suc I., Frisach M.F., Salvayre R., Negre-Salvayre A. Activation of epithelial growth factor receptor pathway by unsaturated fatty acids. Circ. Res. 1999, 85:892-899.
72. Duval C., Auge N., Frisach M.F., Casteilla L., Salvayre R., Negre-Salvayre A. Mitochondrial oxidative stress is modulated by oleic acid via an epidermal growth factor receptor-dependent activation of glutathione peroxidase. Biochem. J. 2002, 367:889-894.
73. Yonezawa T., Haga S., Kobayashi Y., Katoh K., Obara Y. Unsaturated fatty acids promote proliferation via ERK1/2 and Akt pathway in bovine mammary epithelial cells. Biochem. Biophys. Res. Commun. 2008, 367:729-735.
74. Hardy S., Langelier Y., Prentki M. Oleate activates phosphatidylinositol 3-kinase and promotes proliferation and reduces apoptosis of MDA-MB-231 breast cancer cells, whereas palmitate has opposite effects. Cancer Res. 2000, 60:6353-6358.